These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3183862)

  • 1. Parenteral Drug Association response to the FDA compliance policy guide, #7132a.13, entitled, "Parametric release--terminally heat sterilized drug products".
    J Parenter Sci Technol; 1988; 42(4):105. PubMed ID: 3183862
    [No Abstract]   [Full Text] [Related]  

  • 2. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 3. PDA's response to FDA's "Guideline on sterile drug products produced by aseptic processing".
    Akers JE; Agalloco JP; Carleton FJ; Korczynski MS
    J Parenter Sci Technol; 1988; 42(4):114-7. PubMed ID: 3183865
    [No Abstract]   [Full Text] [Related]  

  • 4. Good manufacturing practices and clinical supplies.
    Levchuk JW
    J Parenter Sci Technol; 1991; 45(3):152-5. PubMed ID: 1886044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral Drug Association response to FDA proposal to prohibit the use of any antimicrobial preservative in single-dose parenteral drug products.
    J Parenter Sci Technol; 1985; 39(6):231-2. PubMed ID: 4093824
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA industry relations, a fresh approach.
    Byers TE
    J Parenter Sci Technol; 1983; 37(3):105-6. PubMed ID: 6688270
    [No Abstract]   [Full Text] [Related]  

  • 7. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association.
    J Parenter Sci Technol; 1993; 47(1):4-8. PubMed ID: 8445499
    [No Abstract]   [Full Text] [Related]  

  • 8. An FDA update on GMP's for aseptic processing.
    Fry EM
    J Parenter Sci Technol; 1985; 39(4):154-7. PubMed ID: 3928863
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory aspects of isolation/barrier technology.
    Lyda JC
    PDA J Pharm Sci Technol; 1995; 49(6):300-4. PubMed ID: 8581462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 11. Guideline on control of computerized systems in drug manufacturing. Parenteral Drug Association.
    Matsuda T
    J Pharm Sci Technol; 1994; 48(1):11-5. PubMed ID: 8004411
    [No Abstract]   [Full Text] [Related]  

  • 12. An industry commentary on regulatory issues--microbiology.
    Moldenhauer JE
    PDA J Pharm Sci Technol; 2002; 56(2):60-4. PubMed ID: 11977405
    [No Abstract]   [Full Text] [Related]  

  • 13. PDA response. FDA proposal to amend cGMP's entitled--use of aseptic processing and terminal sterilization in the preparation of sterile pharmaceuticals for human and veterinary use. Parenteral Drug Association.
    J Parenter Sci Technol; 1992; 46(3):65-8. PubMed ID: 1522442
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 15. Year 2000 (Y2K) computer compliance guide; guidance for FDA personnel. Food and Drug Administration. Notice.
    Fed Regist; 1999 May; 64(93):26424-6. PubMed ID: 10558534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDA response. "Guideline for submitting documentation for sterilization process validation in applications for human and veterinary drug products". Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1995; 49(2):62-6. PubMed ID: 7780746
    [No Abstract]   [Full Text] [Related]  

  • 17. Foods--adulteration involving hard or sharp foreign objects; compliance policy guide; availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Apr; 64(62):15774-5. PubMed ID: 10558459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some further comments on aseptic processing guidance, or the fool on the hill: Parenteral Drug Association.
    Agalloco J
    PDA J Pharm Sci Technol; 2003; 57(5):324-30. PubMed ID: 14677624
    [No Abstract]   [Full Text] [Related]  

  • 19. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retesting and laboratory investigations.
    Davis JS
    J Pharm Sci Technol; 1994; 48(3):107-9. PubMed ID: 8069512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.